Cooper Companies | COO - Operating Profit


Cooper Companies reported $140.4M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Abbott USD 2.25B 73M Dec/2025
Align Technology USD 224.71M 40.06M Dec/2025
AtriCure USD 2.49M 2.28M Dec/2025
Avanos Medical USD 24.77M 5.8M Dec/2025
Bausch Health Companies USD 719M 2M Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Bayer EUR -543M 556M Sep/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Boston Scientific USD 1.24B 203M Dec/2025
Cooper Companies USD 140.4M 35.3M Sep/2025
Dentsply International USD 512M 401M Sep/2025
Dexcom USD 323M 80.5M Dec/2025
Edwards Lifesciences USD 370.3M 54.8M Dec/2025
Globus Medical USD 181.31M 298.83M Dec/2025
Haemonetics USD 67.4M 8.9M Dec/2025
Hologic USD 237M 16M Dec/2025
Inogen USD -7.79M 728K Sep/2024
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 11.76M 13.07M Sep/2025
Intuitive Surgical USD 865.3M 97.5M Dec/2025
J&J USD 5.59B 1.81B Dec/2025
Medtronic USD 1.74B 40M Dec/2025
Merit Medical Systems USD 54.2M 11.58M Dec/2025
Novartis USD 4.58B 879M Sep/2025
ResMed USD 497.6M 35.25M Dec/2025
STAAR Surgical USD 18.49M 43.21M Sep/2025
Steris USD 278M 7.1M Dec/2025
Stryker USD 1.97B 609M Dec/2025
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD -408.9M 586.38M Sep/2025
Utah Medical Products USD 3.76M 310K Sep/2024
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025